Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Koutsokera, Z. Daniil, A. I. Papaioannou, T. Kiropoulos, A. Katsabeki, T. Kerenidi, K. I. Gourgoulianis (Larissa, Greece). Oxidative stress in patients with pulmonary sarcoidosis: the role of systemic corticosteroids. Eur Respir J 2007; 30: Suppl. 51, 773

Member's Comments

No comment yet.

Related content which might interest you: Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Systemic inflammation and systemic oxidative stress in acute COPD exacerbation Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Oxidative stress in patients with COPD and pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 161s Year: 2006 Oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Systemic inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Oxidative stress status in patients with chronic obstructive pulmonary disease and its relation to glucocorticoid receptor levels Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008 Rosuvastatin effects on systemic inflammation, oxidative stress and antioxidants in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Oxidant metabolism in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 14S-27S Year: 2003 Drug-induced pulmonary toxicity: a role for anti-oxidants in oxidative stress Source: Annual Congress 2009 - PG7 Drug-induced pulmonary toxicity Year: 2009 Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation Source: Eur Respir J 2014; 43: 1306-1315 Year: 2014 Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002 Markers of resistance to corticosteroids therapy in patients with pulmonary sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Pulmonary arterial manifestation of systemic inflammation in patients with COPD Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Uric acid, oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006 Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Oxidative stress indicators in patients with an exacerbation of COPD Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018